Paladin Labs Announces the Canadian Launch of DigiFab™ Digoxin Immune Fab (Ovine)

Digoxin (also known as digitalis) is a drug used to treat heart failure and to slow the rate in some cardiac conditions. There are approximately 1.6 million digoxin prescriptions written annually in Canada.

Digoxin is known to have a narrow therapeutic window and patients can easily move from a therapeutic to toxic dose through excessive dosing, slow elimination and metabolism or through interactions with other drugs. Digoxin toxicity can cause potentially life-threatening heart rhythm disturbances.

Paladin acquired the exclusive Canadian rights to market and sell DigiFab™ from BTG International Inc., in February 2010.